Dr. Marc Glickman, MD, Chief Medical Officer for HJL, presented at the Veith Vascular Symposium in New York City on November 17, 2016 on “Impact of the VenoValve in patients with Deep Venous Insufficiency”.

Dr. Steve Elias, Principal investigator for the VenoValve human trial will present to the American Venous Forum on February 15, 2017 in New Orleans on The biomechanics of the VenoValve and its impact on patients.

In Vascular News, April 2017, news of the VenoValve and potential impact on patients was discussed in detail in the article. Dr. Elias was lead author and his thoughts about how this valve will impact patients with CVI was discussed in detail.

Hancock Jaffe Lab has sponsored a CME event at the Venous Symposium on April 7th in New York City. The event is tailored to discuss options for treating patients with CVI.